Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matsoukas

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|June 18, 2015
Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple SclerosisStephanie Day, Theodore Tselios, Maria-Eleni Androutsou, et al.
Brain Sciences|December 7, 2018
Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP<sub>82⁻98</sub>) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class IIGeorge Deraos, Eftichia Kritsi, Minos-Timotheos Matsoukas, et al.
Current Medicinal Chemistry|August 22, 2006
Round and round we go: cyclic peptides in diseaseMaria Katsara, Theodore Tselios, Spyros Deraos, et al.
International Journal of Molecular Sciences|June 19, 2024
Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple SclerosisMaria Rodi, Anne-Lise de Lastic, Ioannis Panagoulias, et al.
International Journal of Molecular Sciences|August 30, 2016
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment RegimensMaria Rodi, Nikolaos Dimisianos, Anne-Lise de Lastic, et al.
Journal of Computer-Aided Molecular Design|July 13, 2010
An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studiesGeorge Agelis, Panagiota Roumelioti, Amalia Resvani, et al.
Bioorganic & Medicinal Chemistry|December 3, 2016
Cyclic citrullinated MBP<sub>87-99</sub> peptide stimulates T cell responses: Implications in triggering diseaseVasso Apostolopoulos, George Deraos, Minos-Timotheos Matsoukas, et al.
Current Medicinal Chemistry|June 25, 2005
Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosisAndreas G Tzakos, Anastassios Troganis, Vassiliki Theodorou, et al.
Bioorganic & Medicinal Chemistry|June 24, 2017
Cyclic MOG<sub>35</sub><sub>-</sub><sub>55</sub> ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitisAthanasios Lourbopoulos, George Deraos, Minos-Timotheos Matsoukas, et al.
Immunology|November 26, 2009
Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in miceMaria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|June 18, 2015
Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple SclerosisStephanie Day, Theodore Tselios, Maria-Eleni Androutsou, et al.
Brain Sciences|December 7, 2018
Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP<sub>82⁻98</sub>) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class IIGeorge Deraos, Eftichia Kritsi, Minos-Timotheos Matsoukas, et al.
Current Medicinal Chemistry|August 22, 2006
Round and round we go: cyclic peptides in diseaseMaria Katsara, Theodore Tselios, Spyros Deraos, et al.
International Journal of Molecular Sciences|June 19, 2024
Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple SclerosisMaria Rodi, Anne-Lise de Lastic, Ioannis Panagoulias, et al.
International Journal of Molecular Sciences|August 30, 2016
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment RegimensMaria Rodi, Nikolaos Dimisianos, Anne-Lise de Lastic, et al.
Journal of Computer-Aided Molecular Design|July 13, 2010
An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studiesGeorge Agelis, Panagiota Roumelioti, Amalia Resvani, et al.
Bioorganic & Medicinal Chemistry|December 3, 2016
Cyclic citrullinated MBP<sub>87-99</sub> peptide stimulates T cell responses: Implications in triggering diseaseVasso Apostolopoulos, George Deraos, Minos-Timotheos Matsoukas, et al.
Current Medicinal Chemistry|June 25, 2005
Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosisAndreas G Tzakos, Anastassios Troganis, Vassiliki Theodorou, et al.
Bioorganic & Medicinal Chemistry|June 24, 2017
Cyclic MOG<sub>35</sub><sub>-</sub><sub>55</sub> ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitisAthanasios Lourbopoulos, George Deraos, Minos-Timotheos Matsoukas, et al.
Immunology|November 26, 2009
Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in miceMaria Katsara, Elizabeth Yuriev, Paul A Ramsland, et al.
Pageof 7